Biden names Renee Wegrzyn as first head of ARPA-H

13 September 2022
white-house-america-big

American president Joe Biden is set to appoint Renee Wegrzyn as the first director of the Advanced Research Projects Agency for Health (ARPA-H), a new agency established to drive biomedical innovation.

ARPA-H was created by the Biden Administration in March 2022, with the aim of pushing the limits of US biomedical and health research and innovation. It will embrace proven models of tapping talent and expertise from across industry, academia, and government to bring new ideas and approaches, as well as the ability to marshal resources through public-private partnerships.

The agency is to be underpinned by equitable action, ensuring all projects consider equity in their design, support impactful breakthroughs, expand health care access, and improve access for all patients regardless of race, ethnicity, gender, gender identity, sexual orientation, disability and income level.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical